“…Blood samples for complete blood counts, chemistries, and coagulation variables were obtained just before the infusion (on days 1, 8, and 15), 48 hours after the infusion (on days 3, 10, and 17), and 1 week after the last infusion (day 22). On days 1, 3,6,8,10,13,15,17,20,22, and 24, an assessment of the clinical status of the patient was done. On day 29, at the end-of-trial visit, all pretreatment studies were repeated, including tumor staging and assessment.…”